Business
Oil industry complains about delay in raising margins | The Express Tribune
Points out 50% increase in margins must come into force from mid-Dec 2025, as agreed by ECC
ISLAMABAD:
The Oil Companies Advisory Council (OCAC) has expressed serious concern over failure of the regulator to implement the government’s decision to raise margins of oil companies and over call for full recovery of investment in digitisation.
In a letter to the Oil and Gas Regulatory Authority (Ogra) chairman, OCAC pointed to the absence of a notification for 50% increase in margins of oil marketing companies (OMCs), approved by the Economic Coordination Committee (ECC), for motor spirit (MS) and high-speed diesel (HSD). “As per our understanding, Rs0.61 per litre (out of a total of Rs1.22) was intended to take effect from December 15, 2025, with the remaining 50% linked to the achievement of digitisation targets.”
During the above-stated meeting held on January 14, 2026, the industry was informed that the federal cabinet had advised linkage of the entire increase in margins with 100% digitisation. “While the industry remains fully committed to digitisation, this revised linkage has effectively deferred implementation of even the already-approved immediate increase, thereby placing an additional financial strain on OMCs,” it said. “OMCs continue to operate under a regulated margin framework that has remained stagnant for over two years and does not reflect escalating costs related to operations, financing, compliance and mandatory digitisation initiatives.” OCAC requested Ogra to plead the industry’s case, in coordination with the Ministry of Energy (Petroleum Division), before the cabinet for immediate notification and incorporation of 50% of the approved increase in margin, with effect from December 15, 2025.
Digitisation cost recovery
OCAC recalled that it had already shared the digitisation cost recovery mechanism through a letter dated January 12, 2026. To ensure timely, transparent and equitable recovery of digitisation investments, “it is proposed that a dedicated escrow-type account titled “Digitisation Fund” be created in the MS and HSD price structure, similar to the existing statutory levies (petroleum levy and climate support levy).
The proposed mechanism provides for milestone-based reimbursements, ensuring funds are released against verified implementation, including due compensation of the significant investments already made by the OMCs in digitisation, it said. Under the mechanism, OCAC added that the combined margin of Rs2.56 per litre for the OMCs and dealers was proposed to be included in the price structure as a separate line item, split equally between MS and HSD, ie, Rs1.28 per litre.
It asked Ogra and the Petroleum Division to obtain approval of the ECC for the inclusion of that separate line item and exercise joint oversight over the operation of the fund. It suggested that the account may be maintained as a savings account, with returns further supporting the digitisation initiatives.
The oil industry body also called for immediate reimbursement, within 15 days of the establishment of the mechanism, covering both capital and operational costs. It underlined the need for the recovery of investment in auto tank gauging (ATG) systems already installed at retail outlets and the contribution made by the OMCs to the Raahguzar App as well as the contributions made by the OMCs and refineries to the track and trace system. OCAC proposed setting an initial milestone for the installation of ATGs at 10 retail outlets per OMC, with reimbursement to be initiated within 15 days of the receipt and verification of requisite documentation.
It suggested the continuation of the mechanism until 2030, in line with the digitisation timelines submitted by the OMCs and extension of the mechanism beyond completion for maintenance and future technological upgrades. In the event the above mechanism is not adopted, OCAC proposed structured and ring-fenced recovery through the inland freight equalisation margin (IFEM), by incorporating the approved per-litre digitisation cost into each OMC’s notified cost structure. “In such a case, timely fortnightly recovery and reconciliation would need to be ensured by Ogra.”
The industry lobby emphasised early finalisation of the above matters, given their critical importance to the financial viability, regulatory compliance and uninterrupted supply operations of the OMCs.
Business
Anthropic officially designated a supply chain risk by Pentagon
The supply chain risk designation of the artificial intelligence firm is a first for a US company.
Source link
Business
FDA official calls UniQure’s gene therapy a ‘failed’ treatment for Huntington’s disease
Thomas Fuller | SOPA Images | Lightrocket | Getty Images
UniQure needs to run another study to prove that its gene therapy “actually helps people with Huntington’s disease,” a senior U.S. Food and Drug Administration official said on a call with reporters Thursday.
The official, who requested anonymity before discussing sensitive information, confirmed the agency has asked the company to run a placebo controlled trial of its treatment, which is administered directly into the brain. UniQure has said that type of study isn’t ethical because it would require putting people under general anesthesia for hours, a characterization the official disputed.
“So what is really going on? UniQure is the latest company to make a failed therapy for Huntington’s patients,” the official said. “They likely acknowledge or understand at some deep level that their trial failed years ago, and instead of doing the right thing and running the correct clinical study, UniQure is performing a distorted or manipulated comparison in the mind of FDA.”
The comments mark the latest development in a messy public spat between UniQure and the FDA, and as the agency comes under fire for a number of recent drug approval application rejections, including some where companies have accused it of going back on previous guidance. FDA Commissioner Marty Makary in an interview with CNBC’s Becky Quick last week seemingly criticized UniQure’s gene therapy for Huntington’s disease. Makary didn’t name UniQure but described its treatment.
UniQure then accused the FDA of reversing its stance that the company’s clinical trial data would be sufficient to seek approval. UniQure’s study used an outside database to measure how patients with Huntington’s disease might decline without treatment, known as an external control. UniQure has said it wouldn’t be feasible to run a true randomized, double-blind placebo-controlled study, considered the gold standard, because it wouldn’t be ethical to make people undergo a sham hours-long brain surgery.
The FDA official said the agency “never agreed to accept this distorted comparison” and the FDA “never makes such assurances.” Instead, the “FDA will always say, ‘Well, we have to see the data when we get it.'”
UniQure didn’t immediately comment.
The company’s stock rose more than 10% on Thursday and has fallen 58% this year as of Thursday afternoon.
Business
US mortgage rates rise to 6% after three-week slide as oil-driven bond yields climb – The Times of India
The average long-term US mortgage rate edged higher this week, ending a three-week decline as bond yields rose amid oil-price pressures linked to the war with Iran.The benchmark 30-year fixed mortgage rate increased to 6% from 5.98% last week, mortgage buyer Freddie Mac said on Thursday. A year ago, the average rate stood at 6.63%, AP reported.The modest uptick breaks a three-week slide in borrowing costs, with mortgage rates having hovered close to the 6% mark for most of this year. Last week’s average had marked the first time the rate dipped below 6% since September 2022, reaching its lowest level in nearly three and a half years.Mortgage rates are influenced by several factors, including the Federal Reserve’s interest-rate policy, investor expectations about inflation and economic growth, and movements in the bond market.They typically track the direction of the 10-year US Treasury yield, which lenders use as a benchmark for pricing home loans.The 10-year Treasury yield rose to 4.14% at midday Thursday, up from around 4% a week earlier.Treasury yields have moved higher in recent days as rising oil prices added fresh inflation concerns, potentially complicating the Federal Reserve’s plans to cut interest rates.
-
Business1 week agoAttock Cement’s acquisition approved | The Express Tribune
-
Politics1 week agoWhat are Iran’s ballistic missile capabilities?
-
Business7 days agoIndia Us Trade Deal: Fresh look at India-US trade deal? May be ‘rebalanced’ if circumstances change, says Piyush Goyal – The Times of India
-
Politics1 week agoUS arrests ex-Air Force pilot for ‘training’ Chinese military
-
Fashion1 week agoPolicy easing drives Argentina’s garment import surge in 2025
-
Sports1 week agoSri Lanka’s Shanaka says constant criticism has affected players’ mental health
-
Sports6 days agoLPGA legend shares her feelings about US women’s Olympic wins: ‘Gets me really emotional’
-
Fashion7 days agoTexwin Spinning showcasing premium cotton yarn range at VIATT 2026
